Moderna (MRNA) faces major commercial setbacks as mRNA vaccines underperform against traditional competitors in post-pandemic markets. RSV and flu mRNA vaccines struggle with lower durability, higher ...
mRNA, often referred to as the "blueprint of life," is a crucial molecule involved in protein synthesis. It carries genetic information from DNA, the genetic code, to the cell's protein-making ...
MRNA received a unanimous advisory committee vote supporting mRNA-1010, its flu vaccine, for adults 50 and older. MRNA plans to launch mRNA-1010 for the 2026/2027 season, but is not guiding for a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results